Jan 11, 2023 / 06:30PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
Good morning. I'm Eric Joseph, senior biotech analyst with JPMorgan. Our next presenting company is Karyopharm Therapeutics. And presenting on the part of the company is CEO, Richard Paulson, and Chief Medical Officer, Reshma Rangwala. There's a Q&A session after the presentation, just raise your hand, we'll get a mic to you. And for those tuning in via the webcast, feel free to submit questions via the digital conference book, and we'll work them in where appropriate. So with that, Richard?
Richard A. Paulson - Karyopharm Therapeutics Inc. - President, CEO & Director
Good morning, everyone, and thank you, Eric, for hosting us this morning at the JPMorgan Conference. It is invigorating to be able to see everyone in person, and it's a little bit wet to be running outside. We're really pleased to be able to update everybody on the progress that Karyopharm has made in the last year and our plans moving forward to continue to generate value for patients and shareholders
Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot